Cargando…
The role of gut microbiota in cancer treatment: friend or foe?
The gut microbiota has been implicated in cancer and shown to modulate anticancer drug efficacy. Altered gut microbiota is associated with resistance to chemo drugs or immune checkpoint inhibitors (ICIs), whereas supplementation of distinct bacterial species restores responses to the anticancer drug...
Autores principales: | Cheng, Wing Yin, Wu, Chun-Ying, Yu, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7497589/ https://www.ncbi.nlm.nih.gov/pubmed/32759302 http://dx.doi.org/10.1136/gutjnl-2020-321153 |
Ejemplares similares
-
Advancing human gut microbiota research by considering gut transit time
por: Procházková, Nicola, et al.
Publicado: (2023) -
The gut microbiota and host health: a new clinical frontier
por: Marchesi, Julian R, et al.
Publicado: (2016) -
Mucus barrier, mucins and gut microbiota: the expected slimy partners?
por: Paone, Paola, et al.
Publicado: (2020) -
Gut microbiota-derived metabolites as central regulators in metabolic disorders
por: Agus, Allison, et al.
Publicado: (2021) -
Cancer pharmacomicrobiomics: targeting microbiota to optimise cancer therapy outcomes
por: Ting, Nick Lung-Ngai, et al.
Publicado: (2022)